|1.||Rafter, Joseph: 3 articles (12/2009 - 05/2008)|
|2.||Morales, Paloma: 3 articles (12/2009 - 05/2008)|
|3.||García, Almudena: 3 articles (12/2009 - 05/2008)|
|4.||Haza, Ana I: 3 articles (12/2009 - 05/2008)|
|5.||Arranz, Nuria: 2 articles (07/2009 - 05/2008)|
|6.||Shen, Jian: 1 article (08/2010)|
|7.||Xu, Li-Yan: 1 article (08/2010)|
|8.||Shen, Zhong-Ying: 1 article (08/2010)|
|9.||Xie, Xiao-Yuan: 1 article (08/2010)|
|10.||Li, En-Min: 1 article (08/2010)|
07/01/1981 - "[Morphological studies on tumors of the nasal cavity induced in rats by N-nitrosopiperidine (author's transl)]."
12/01/1971 - "Histopathological and ultrastructural studies on esophageal tumors in rats treated with N-nitrosopiperidine."
08/01/2010 - "Bronchogenic and alveologenic tumors in mice induced by N-nitrosopiperidine."
01/01/1990 - "Histological types of laryngotracheal tumors induced in Syrian golden hamsters by nitrosomorpholine and nitrosopiperidine."
06/01/1986 - "N-Nitrosopiperidine (CAS: 100-75-4) and 2,6-dimethylnitrosomorpholine induced tumors of the olfactory epithelium in white Wistar rats. "
|2.||Hepatocellular Carcinoma (Hepatoma)
06/01/1993 - "Ornithine decarboxylase (ODC) activity was assessed in fetal, regenerating and adult rat liver, in hepatoma with different growth rate, in Morris hepatoma cell lines and in rat liver in the course of nitrosopiperidine (NP) carcinogenesis. "
12/01/2009 - "The human hepatoma cell line (HepG2) exhibited a dose and time-dependent apoptotic response following treatment with N-Nitrosopiperidine (NPIP) and N-Nitrosodibutylamine (NDBA), two recognized human carcinogens. "
10/01/2009 - "The aim of this study was to investigate the protective effect of myricetin, quercetin, (+)-catechin and (-)-epicatechin, against N-nitrosodibutylamine (NDBA) and N-nitrosopiperidine (NPIP)-induced DNA damage in human hepatoma cells (HepG2). "
07/01/2009 - "The aim of this work was to determine the effect of vitamin C, diallyl disulfide (DADS) and dipropyl disulfide (DPDS) towards N-nitrosopiperidine (NPIP) and N-nitrosodibutylamine (NDBA)-induced apoptosis in human leukemia (HL-60) and hepatoma (HepG2) cell lines using the terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling assay. "
|3.||Body Weight (Weight, Body)
12/01/1991 - "Studies of 16 different concentrations of N-nitrosopyrrolidine and N-nitrosopiperidine given from age 6 weeks onwards to small groups of rats yielded dose-response relationships for the effects of N-nitrosopyrrolidine on liver tumors and for those of N-nitrosopiperidine on tumors of the liver and upper gastrointestinal tract that resembled those seen for NDMA and NDEA, respectively, except that N-nitrosopyrrolidine and N-nitrosopiperidine were less potent [the respective dose rates needed to halve the proportion of tumorless survivors after 2 years of treatment being approximately 0.4 (males) and 0.6 (females) mg/kg adult body weight/day for each agent]. "
01/01/1987 - "Guinea-pigs were fed diets containing 48, 200 or 2000 mg/kg ascorbic acid (AsA) for 20-30 days and given a single oral dose of 50 mg N-nitrosopiperidine (NPIP)/kg body weight. "
|4.||Ascorbic Acid Deficiency (Vitamin C Deficiency)
01/01/1982 - "Effect of amino acids imbalance and ascorbic acid deficiency on carcinogenic action of N-nitrosopiperidine in guinea pigs."
03/01/1981 - "A study was made of the effect of ascorbic acid deficiency and low levels of lysine, methionine and threonine on the cancerogenic effect of nitrosopiperidine which was fed to guinea-pigs with drinking water in a single dose of 4.25 mg/kg bw. "
|5.||Lung Neoplasms (Lung Cancer)
|8.||Catechin (Z 7300)